NCT00282997已完成3 期
A 12-Week, Open-Label, Safety Trial Of Pregabalin In Patients With Fibromyalgia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.72 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2006年2月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 500
- 试验地点
- 72
- 主要终点
- To evaluate the safety of pregabalin in patients with fibromyalgia
研究概览
简要总结
To evaluate the safety of pregabalin in patients with fibromyalgia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must meet the ACR criteria for fibromyalgia (ie, widespread pain present for at least 3 months, and pain in at least 11 of 18 specific tender point sites.
- •Patients must complete the double-blind study.
排除标准
- •Patients who experienced a serious adverse event during the previous fibromyalgia study, which was determined to be related to the study medication.
结局指标
主要结局
To evaluate the safety of pregabalin in patients with fibromyalgia
次要结局
未报告次要终点
研究者
研究点 (72)
Loading locations...
相似试验
已完成
3 期
This Study is An Open-Label Trial Of Pregabalin In Patients With FibromyalgiaFibromyalgiaNCT00346034Pfizer's Upjohn has merged with Mylan to form Viatris Inc.357
终止
3 期
Pregabalin Trial In HIV Neuropathic PainHIV-1 InfectionNeuropathic PainNCT01145417Pfizer's Upjohn has merged with Mylan to form Viatris Inc.217
已完成
不适用
Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)Pain Associated With FibromyalgiaNCT01773993Pfizer's Upjohn has merged with Mylan to form Viatris Inc.534
已完成
1 期
An fMRI Study Of Brain Response In Patients With FibromyalgiaFibromyalgiaNCT00760474Pfizer's Upjohn has merged with Mylan to form Viatris Inc.27
已完成
不适用
Study of Gralise to Treat Fibromyalgia PatientsFibromyalgiaNCT02052414The Center for Clinical Research, Winston-Salem, NC34